{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T23:51:22Z","timestamp":1787615482241,"version":"build-2736575974"},"reference-count":171,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.cca.2025.120397","type":"journal-article","created":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T18:36:32Z","timestamp":1748370992000},"page":"120397","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Emerging blood biomarkers in Alzheimer\u2019s disease: a proteomic perspective"],"prefix":"10.1016","volume":"576","author":[{"given":"Neeraj","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neetu","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakhi","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.M.","family":"Rekha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya Priyadarshini","family":"Nayak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandeep","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Khachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavita","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Rekha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohit","family":"Rana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghala","family":"Alnuaimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashi","family":"Kulshrestha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cca.2025.120397_b0005","first-page":"39","article-title":"Alzheimer's disease: a healthcare burden of epidemic proportion","volume":"2","author":"Dharmarajan","year":"2009","journal-title":"Am. Health Drug Benefits"},{"issue":"48","key":"10.1016\/j.cca.2025.120397_b0010","doi-asserted-by":"crossref","first-page":"33032","DOI":"10.1021\/acsnano.4c05693","article-title":"Multi targeted therapy for Alzheimer's disease by guanidinium-modified calixarene and cyclodextrin co-assembly loaded with insulin","volume":"18","author":"Zhang","year":"2024","journal-title":"ACS Nano"},{"issue":"D1","key":"10.1016\/j.cca.2025.120397_b0015","doi-asserted-by":"crossref","first-page":"D1151","DOI":"10.1093\/nar\/gkae1008","article-title":"sc2GWAS: a comprehensive platform linking single cell and GWAS traits of human","volume":"53","author":"Yin","year":"2024","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"10.1016\/j.cca.2025.120397_b0020","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006148","article-title":"The clinical problem of symptomatic Alzheimer disease and mild cognitive impairment","volume":"2","author":"Tarawneh","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"1","key":"10.1016\/j.cca.2025.120397_b0025","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s13311-022-01201-2","article-title":"Disease-modifying therapies for alzheimer's disease: more questions than answers","volume":"19","author":"Golde","year":"2022","journal-title":"Neurotherapeutics"},{"issue":"5","key":"10.1016\/j.cca.2025.120397_b0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-019-0250-2","article-title":"Diagnosis of Alzheimer's disease utilizing amyloid and tau as fluid biomarkers","volume":"51","author":"Lee","year":"2019","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.cca.2025.120397_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2025.118369","article-title":"Associations among blood heavy metals, neurofilament light chains and cognition function in US adults: NHANES 2013-2014","volume":"299","author":"Zhou","year":"2025","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"10.1016\/j.cca.2025.120397_b0040","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3389\/fphar.2019.00395","article-title":"Apelin-13 suppresses neuroinflammation against cognitive deficit in a streptozotocin-induced rat model of Alzheimer's disease through activation of BDNF-TrkB signaling pathway","volume":"10","author":"Luo","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.cca.2025.120397_b0045","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2025.1492804","article-title":"Early identification of mild cognitive impairment: an innovative model using ocular biomarkers","volume":"17","author":"Zhang","year":"2025","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.cca.2025.120397_b0050","article-title":"Mapping the intersection of HIV and Alzheimer's disease: a bibliometric analysis of emerging research trends","volume":"16","author":"Zhang","year":"2025","journal-title":"Front. Neurol."},{"issue":"4","key":"10.1016\/j.cca.2025.120397_b0055","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s11030-018-9839-y","article-title":"Structure-activity relationship investigation of coumarin-chalcone hybrids with diverse side-chains as acetylcholinesterase and butyrylcholinesterase inhibitors","volume":"22","author":"Kang","year":"2018","journal-title":"Mol. Divers."},{"issue":"4","key":"10.1016\/j.cca.2025.120397_b0060","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1002\/ddr.21515","article-title":"Structure-activity study of fluorine or chlorine-substituted cinnamic acid derivatives with tertiary amine side chain in acetylcholinesterase and butyrylcholinesterase inhibition","volume":"80","author":"Gao","year":"2019","journal-title":"Drug Dev. Res."},{"issue":"5","key":"10.1016\/j.cca.2025.120397_b0065","doi-asserted-by":"crossref","DOI":"10.1111\/cns.70422","article-title":"Blood-Brain Barrier (BBB) dysfunction in CNS diseases: paying attention to pericytes","volume":"31","author":"Yu","year":"2025","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.cca.2025.120397_b0070","doi-asserted-by":"crossref","DOI":"10.1001\/jamainternmed.2025.0976","article-title":"The limited role of alzheimer disease blood-based biomarkers in primary care","author":"Widera","year":"2025","journal-title":"JAMA Intern. Med."},{"issue":"4","key":"10.1016\/j.cca.2025.120397_b0075","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70114","article-title":"Plasma biomarkers as core mediators in functional network abnormalities: Evidence from a two-cohort study","volume":"21","author":"Wei","year":"2025","journal-title":"Alzheimers Dement."},{"issue":"4","key":"10.1016\/j.cca.2025.120397_b0080","first-page":"1309","article-title":"Research progress and clinical application potential of silicon-based microring resonators in biomedical detection","volume":"41","author":"Wang","year":"2025","journal-title":"Sheng Wu Gong Cheng Xue Bao"},{"key":"10.1016\/j.cca.2025.120397_b0085","article-title":"Untargeted metabolomics analysis of the hippocampus and cerebral cortex identified the neuroprotective mechanisms of Bushen Tiansui formula in an a\u03b2(25-35)-induced rat model of Alzheimer's disease","volume":"13","author":"Li","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"8","key":"10.1016\/j.cca.2025.120397_b0090","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26083541","article-title":"Associations between GFAP, A\u03b242\/40 ratio, and perivascular spaces and cognitive domains in vascular cognitive impairment","volume":"26","author":"Wang","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cca.2025.120397_b0095","doi-asserted-by":"crossref","DOI":"10.1007\/s12035-025-05026-w","article-title":"Exploring exosome-based approaches for early diagnosis and treatment of neurodegenerative diseases","author":"Varshney","year":"2025","journal-title":"Mol. Neurobiol."},{"issue":"8","key":"10.1016\/j.cca.2025.120397_b0100","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/ddr.21726","article-title":"Nitrogen-containing flavonoid and their analogs with diverse B-ring in acetylcholinesterase and butyrylcholinesterase inhibition","volume":"81","author":"Lu","year":"2020","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.cca.2025.120397_b0105","doi-asserted-by":"crossref","DOI":"10.1007\/s41999-025-01222-y","article-title":"Multimorbidity and fluid biomarkers of Alzheimer's disease: a systematic review","author":"Valletta","year":"2025","journal-title":"Eur. Geriatr. Med."},{"issue":"9","key":"10.1016\/j.cca.2025.120397_b0110","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26094271","article-title":"From synaptic plasticity to neurodegeneration: BDNF as a transformative target in medicine","volume":"26","author":"Toader","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cca.2025.120397_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113392","article-title":"Unlocking the full potential of memory T cells in adoptive T cell therapy for hematologic malignancies","volume":"144","author":"Sun","year":"2025","journal-title":"Int. Immunopharmacol."},{"issue":"5","key":"10.1016\/j.cca.2025.120397_b0120","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70303","article-title":"Physical and biopsychosocial frailty, cognitive phenotypes, and plasma biomarkers for Alzheimer's disease in Chinese older adults: a population-based study","volume":"21","author":"Tian","year":"2025","journal-title":"Alzheimers Dement."},{"issue":"3","key":"10.1016\/j.cca.2025.120397_b0125","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1192\/bjo.2025.62","article-title":"Future directions for brain health clinics","volume":"11","author":"Tan","year":"2025","journal-title":"Bjpsych Open"},{"issue":"10","key":"10.1016\/j.cca.2025.120397_b0130","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.70366","article-title":"Brain derived neurotrophic factor and secreted amyloid precursor protein-\u03b1 response to moderate and high intensity exercise","volume":"13","author":"Spencer","year":"2025","journal-title":"Physiol. Rep."},{"key":"10.1016\/j.cca.2025.120397_b0135","first-page":"85","article-title":"Advances in blood biomarkers for Alzheimer's disease: ultra-sensitive detection technologies and impact on clinical diagnosis","volume":"14","author":"Zhang","year":"2024","journal-title":"Degener. Neurol. Neuromuscul. Dis."},{"issue":"18","key":"10.1016\/j.cca.2025.120397_b0140","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1016\/j.neuron.2023.05.017","article-title":"Blood-based biomarkers for Alzheimer's disease: Current state and future use in a transformed global healthcare landscape","volume":"111","author":"Hampel","year":"2023","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.cca.2025.120397_b0145","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1002\/alz.13542","article-title":"Plasma A\u03b242\/A\u03b240 and phospho-tau217 concentration ratios increase the accuracy of amyloid PET classification in preclinical Alzheimer's disease","volume":"20","author":"Rissman","year":"2024","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.cca.2025.120397_b0150","article-title":"Revealing the potential therapeutic mechanism of Lonicerae Japonicae Flos in Alzheimer's disease: a computational biology approach","volume":"11","author":"Xiang","year":"2024","journal-title":"Front. Med. (lausanne)"},{"issue":"2","key":"10.1016\/j.cca.2025.120397_b0155","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1016\/S2666-7568(20)30061-1","article-title":"Serum markers glial fibrillary acidic protein and neurofilament light for prognosis and monitoring in cognitively normal older people: a prospective memory clinic-based cohort study","volume":"2","author":"Verberk","year":"2021","journal-title":"Lancet Healthy Longev"},{"key":"10.1016\/j.cca.2025.120397_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.ensci.2025.100550","article-title":"The role of Neurofilament light (NfL) and glial fibrillary acidic protein (GFAP) in MS and AQP4-NMOSD: Advancing clinical applications","volume":"38","author":"Samadzadeh","year":"2025","journal-title":"eNeurologicalSci"},{"issue":"4","key":"10.1016\/j.cca.2025.120397_b0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0034341","article-title":"Multivariate protein signatures of pre-clinical Alzheimer's disease in the Alzheimer's disease neuroimaging initiative (ADNI) plasma proteome dataset","volume":"7","author":"Johnstone","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.cca.2025.120397_b0170","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00401-010-0723-9","article-title":"Biomarker discovery for Alzheimer's disease, frontotemporal lobar degeneration, and Parkinson's disease","volume":"120","author":"Hu","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.cca.2025.120397_b0175","unstructured":"Enders, K., et al., Pre-analytical pitfalls: how blood collection tubes influence exercise-induced cell-free DNA concentrations. Experim. Physiol., n\/a(n\/a)."},{"issue":"1","key":"10.1016\/j.cca.2025.120397_b0180","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s12967-025-06298-5","article-title":"Proteomic analysis reveals chromatin remodeling as a potential therapeutical target in neuroblastoma","volume":"23","author":"Liu","year":"2025","journal-title":"J. Transl. Med."},{"issue":"2","key":"10.1016\/j.cca.2025.120397_b0185","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11020335","article-title":"The future of precision medicine in the cure of Alzheimer's disease","volume":"11","author":"Arafah","year":"2023","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.cca.2025.120397_b0190","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s13311-016-0481-z","article-title":"Biomarkers for the early detection and progression of Alzheimer's disease","volume":"14","author":"Counts","year":"2017","journal-title":"Neurotherapeutics"},{"issue":"1","key":"10.1016\/j.cca.2025.120397_b0195","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s13195-023-01314-6","article-title":"Biomarkers in Alzheimer's disease: role in early and differential diagnosis and recognition of atypical variants","volume":"15","author":"Dubois","year":"2023","journal-title":"Alzheimers Res. Ther."},{"issue":"5","key":"10.1016\/j.cca.2025.120397_b0200","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/s41591-020-0815-6","article-title":"Large-scale proteomic analysis of Alzheimer's disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation","volume":"26","author":"Johnson","year":"2020","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.cca.2025.120397_b0205","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/jnc.15465","article-title":"Mass spectrometry-based methods for robust measurement of Alzheimer's disease biomarkers in biological fluids","volume":"159","author":"Korecka","year":"2021","journal-title":"J. Neurochem."},{"issue":"10","key":"10.1016\/j.cca.2025.120397_b0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2023.100629","article-title":"Methods to discover and validate biofluid-based biomarkers in neurodegenerative dementias","volume":"22","author":"Teunissen","year":"2023","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.cca.2025.120397_b0215","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2021.5598","article-title":"Neurologic prognostication after cardiac arrest using brain biomarkers: a systematic review and meta-analysis","volume":"79","author":"Hoiland","year":"2022","journal-title":"JAMA Neurol."},{"issue":"1","key":"10.1016\/j.cca.2025.120397_b0220","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13024-023-00605-8","article-title":"Plasma phospho-tau in Alzheimer's disease: towards diagnostic and therapeutic trial applications","volume":"18","author":"Gonzalez-Ortiz","year":"2023","journal-title":"Mol. Neurodegener."},{"issue":"10","key":"10.1016\/j.cca.2025.120397_b0225","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1515\/cclm-2015-1195","article-title":"Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa","volume":"54","author":"Kuhle","year":"2016","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.cca.2025.120397_b0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanepe.2024.101009","article-title":"Fluid biomarkers in multiple sclerosis: from current to future applications","volume":"44","author":"Di Filippo","year":"2024","journal-title":"Lancet Regional Health - Europe"},{"issue":"11","key":"10.1016\/j.cca.2025.120397_b0235","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000213706","article-title":"Olfaction and Plasma Biomarkers of Alzheimer Disease and Neurodegeneration in the Atherosclerosis Risk in Communities Study","volume":"104","author":"Shrestha","year":"2025","journal-title":"Neurology"},{"key":"10.1016\/j.cca.2025.120397_b0240","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.neurobiolaging.2025.04.011","article-title":"Longitudinal relationships among cerebrospinal fluid biomarkers, cerebral blood flow, and grey matter volume in individuals with a familial history of Alzheimer's disease","volume":"152","author":"Sanami","year":"2025","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.cca.2025.120397_b0245","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2025.1581892","article-title":"Multi-pathway blood biomarkers to target and monitor multidimensional prevention of cognitive and functional decline (nested in the IN-TeMPO study framed within the world-wide FINGERS network)","volume":"17","author":"Sala","year":"2025","journal-title":"Front. Aging Neurosci."},{"issue":"5","key":"10.1016\/j.cca.2025.120397_b0250","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70201","article-title":"Global multi-specialty clinician perspectives on the implementation of Alzheimer's disease blood biomarkers","volume":"21","author":"Rodda","year":"2025","journal-title":"Alzheimers Dement."},{"issue":"11","key":"10.1016\/j.cca.2025.120397_b0255","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1093\/brain\/awaa286","article-title":"Longitudinal plasma p-tau217 is increased in early stages of Alzheimer's disease","volume":"143","author":"Mattsson-Carlgren","year":"2020","journal-title":"Brain"},{"issue":"9","key":"10.1016\/j.cca.2025.120397_b0260","doi-asserted-by":"crossref","first-page":"6183","DOI":"10.1002\/alz.14100","article-title":"Longitudinal plasma phosphorylated-tau217 and other related biomarkers in a non-demented Alzheimer's risk-enhanced sample","volume":"20","author":"Du","year":"2024","journal-title":"Alzheimers Dement."},{"issue":"3","key":"10.1016\/j.cca.2025.120397_b0265","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70038","article-title":"Diagnostic accuracy of plasma p-tau217\/A\u03b242 for Alzheimer's disease in clinical and community cohorts","volume":"21","author":"Wang","year":"2025","journal-title":"Alzheimers Dement."},{"issue":"1","key":"10.1016\/j.cca.2025.120397_b0270","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40035-024-00412-1","article-title":"Pathophysiological subtypes of mild cognitive impairment due to Alzheimer's disease identified by CSF proteomics","volume":"13","author":"Moutinho","year":"2024","journal-title":"Transl Neurodegener"},{"issue":"1","key":"10.1016\/j.cca.2025.120397_b0275","doi-asserted-by":"crossref","first-page":"4993","DOI":"10.1038\/s41598-025-89334-0","article-title":"Gene network analysis identifies dysregulated pathways in an autism spectrum disorder caused by mutations in Transcription Factor 4","volume":"15","author":"de Carvalho","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cca.2025.120397_b0280","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awaf167","article-title":"Altered T-cell reactivity in the early stages of Alzheimer's disease","author":"Rickenbach","year":"2025","journal-title":"Brain"},{"key":"10.1016\/j.cca.2025.120397_b0285","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2025.1516746","article-title":"An exploratory analysis of bezisterim treatment associated with decreased biological age acceleration, and improved clinical measure and biomarker changes in mild-to-moderate probable Alzheimer's disease","volume":"19","author":"Reading","year":"2025","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.cca.2025.120397_b0290","doi-asserted-by":"crossref","DOI":"10.1177\/13872877251340955","article-title":"Blood biomarkers of amyloid and tau pathologies, brain degeneration, inflammation, and oxidative stress in early- and late-onset Alzheimer's disease","author":"Qin","year":"2025","journal-title":"J. Alzheimers Dis."},{"issue":"4","key":"10.1016\/j.cca.2025.120397_b0295","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70219","article-title":"Brain outcomes with lifestyle change in adults with Down syndrome: Rationale and design for a 12-month randomized trial","volume":"21","author":"Ptomey","year":"2025","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.cca.2025.120397_b0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2025.110462","article-title":"Fibrillar structures detected by AFM in the cerebrospinal fluid of patients affected by Alzheimer's disease and other neurological conditions","volume":"770","author":"Polykretis","year":"2025","journal-title":"Arch. Biochem. Biophys."},{"issue":"2","key":"10.1016\/j.cca.2025.120397_b0305","article-title":"Tau-targeting nanoparticles for treatment of Alzheimer's disease","volume":"5","author":"Pawar","year":"2025","journal-title":"Exploration (beijing)"},{"issue":"4","key":"10.1016\/j.cca.2025.120397_b0310","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/s41574-021-00626-7","article-title":"Mitochondrial and metabolic dysfunction in ageing and age-related diseases","volume":"18","author":"Amorim","year":"2022","journal-title":"Nat. Rev. Endocrinol."},{"issue":"1","key":"10.1016\/j.cca.2025.120397_b0315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1021\/acschemneuro.3c00531","article-title":"Aging Hallmarks and Progression and Age-Related Diseases: A Landscape View of Research Advancement","volume":"15","author":"Tenchov","year":"2024","journal-title":"ACS Chem. Nerosci."},{"issue":"3","key":"10.1016\/j.cca.2025.120397_b0320","doi-asserted-by":"crossref","first-page":"704","DOI":"10.3390\/biom4030704","article-title":"Chaperoning proteins for destruction: diverse roles of Hsp70 chaperones and their co-chaperones in targeting misfolded proteins to the proteasome","volume":"4","author":"Shiber","year":"2014","journal-title":"Biomolecules"},{"issue":"10","key":"10.1016\/j.cca.2025.120397_b0325","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/nrm3658","article-title":"Chaperone machines for protein folding, unfolding and disaggregation","volume":"14","author":"Saibil","year":"2013","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.cca.2025.120397_b0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117084","article-title":"New insights into the role of mitochondrial dynamics in oxidative stress-induced diseases","volume":"178","author":"Chen","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.cca.2025.120397_b0335","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/bs.ircmb.2018.05.006","article-title":"Mitochondria and reactive oxygen species in aging and age-related diseases","volume":"340","author":"Giorgi","year":"2018","journal-title":"Int. Rev. Cell Mol. Biol."},{"issue":"9","key":"10.1016\/j.cca.2025.120397_b0340","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13684","article-title":"Plasma proteome profiling of healthy individuals across the life span in a Sicilian cohort with long-lived individuals","volume":"21","author":"Siino","year":"2022","journal-title":"Aging Cell"},{"issue":"10","key":"10.1016\/j.cca.2025.120397_b0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.cub.2014.03.034","article-title":"ROS function in redox signaling and oxidative stress","volume":"24","author":"Schieber","year":"2014","journal-title":"Curr. Biol."},{"key":"10.1016\/j.cca.2025.120397_b0350","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.redox.2014.01.017","article-title":"Molecular chaperones and proteostasis regulation during redox imbalance","volume":"2","author":"Niforou","year":"2014","journal-title":"Redox Biol."},{"issue":"6","key":"10.1016\/j.cca.2025.120397_b0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2005.10.049","article-title":"Inflammatory markers and loss of muscle mass (sarcopenia) and strength","volume":"119","author":"Schaap","year":"2006","journal-title":"Am. J. Med."},{"issue":"12","key":"10.1016\/j.cca.2025.120397_b0360","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/s41576-022-00511-7","article-title":"Measuring biological age using omics data","volume":"23","author":"Rutledge","year":"2022","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.cca.2025.120397_b0365","series-title":"Epigenetic Clocks: Beyond Biological Age","author":"Liang","year":"2024"},{"issue":"6","key":"10.1016\/j.cca.2025.120397_b0370","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.3945\/ajcn.2009.27807","article-title":"Leukocyte telomere length: the telomere tale continues","volume":"89","author":"Aviv","year":"2009","journal-title":"Am. J. Clin. Nutr."},{"issue":"1\u20132","key":"10.1016\/j.cca.2025.120397_b0375","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.mrfmmm.2011.05.001","article-title":"Genetics of leukocyte telomere length and its role in atherosclerosis","volume":"730","author":"Aviv","year":"2012","journal-title":"Mutat. Res."},{"issue":"8","key":"10.1016\/j.cca.2025.120397_b0380","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1007\/s00415-022-11055-5","article-title":"Plasma neurofilament light chain as a biomarker of Alzheimer's disease in Subjective Cognitive Decline and Mild Cognitive Impairment","volume":"269","author":"Giacomucci","year":"2022","journal-title":"J. Neurol."},{"issue":"Suppl 3","key":"10.1016\/j.cca.2025.120397_b0385","doi-asserted-by":"crossref","first-page":"S133","DOI":"10.21037\/atm.2019.05.81","article-title":"Serum neurofilament light chain rate of change in Alzheimer's disease: potentials applications and notes of caution","volume":"7","author":"Massa","year":"2019","journal-title":"Ann Transl Med"},{"issue":"1","key":"10.1016\/j.cca.2025.120397_b0390","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/alz.13450","article-title":"Astrocyte biomarkers GFAP and YKL-40 mediate early Alzheimer's disease progression","volume":"20","author":"Pelkmans","year":"2024","journal-title":"Alzheimers Dement."},{"issue":"1","key":"10.1016\/j.cca.2025.120397_b0395","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.24m15558","article-title":"Plasma NfL, P-tau181, and P-tau181\/A\u03b242 ratio in predicting mild behavioral impairment in dementia-free multiethnic asian older adults with mixed pathology in a 5-year clinical cohort","volume":"86","author":"Liao","year":"2025","journal-title":"J. Clin. Psychiatry"},{"issue":"4","key":"10.1016\/j.cca.2025.120397_b0400","article-title":"Plasma p-tau217, p-tau181, and NfL as early indicators of dementia risk in a community cohort: The Shanghai Aging Study","volume":"15","author":"Xiao","year":"2023","journal-title":"Alzheimers Dement. (amst)"},{"issue":"1","key":"10.1016\/j.cca.2025.120397_b0405","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40035-024-00412-1","article-title":"Pathophysiological subtypes of mild cognitive impairment due to Alzheimer\u2019s disease identified by CSF proteomics","volume":"13","author":"Moutinho","year":"2024","journal-title":"Transl. Neurodegenerat."},{"key":"10.1016\/j.cca.2025.120397_b0410","series-title":"International Review of Cell and Molecular Biology","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/bs.ircmb.2018.05.006","author":"Giorgi","year":"2018"},{"issue":"1","key":"10.1016\/j.cca.2025.120397_b0415","doi-asserted-by":"crossref","DOI":"10.1002\/alz.14397","article-title":"Plasma p-tau immunoassays in clinical research for Alzheimer's disease","volume":"21","author":"Teunissen","year":"2025","journal-title":"Alzheimers Dement."},{"issue":"1","key":"10.1016\/j.cca.2025.120397_b0420","doi-asserted-by":"crossref","first-page":"4466","DOI":"10.1038\/s41467-023-40208-x","article-title":"Compilation of reported protein changes in the brain in Alzheimer's disease","volume":"14","author":"Askenazi","year":"2023","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.cca.2025.120397_b0425","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S1474-4422(21)00214-3","article-title":"Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study","volume":"20","author":"Thijssen","year":"2021","journal-title":"Lancet Neurol."},{"issue":"8","key":"10.1016\/j.cca.2025.120397_b0430","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12081836","article-title":"P-tau217 as a reliable blood-based marker of Alzheimer's disease","volume":"12","author":"Lai","year":"2024","journal-title":"Biomedicines"},{"issue":"6","key":"10.1016\/j.cca.2025.120397_b0435","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/s43587-023-00405-1","article-title":"Mass spectrometric simultaneous quantification of tau species in plasma shows differential associations with amyloid and tau pathologies","volume":"3","author":"Montoliu-Gaya","year":"2023","journal-title":"Nat. Aging"},{"issue":"1","key":"10.1016\/j.cca.2025.120397_b0440","doi-asserted-by":"crossref","first-page":"34","DOI":"10.14283\/jpad.2018.41","article-title":"Plasma A\u03b242\/40 ratio detects early stages of Alzheimer's disease and correlates with CSF and neuroimaging biomarkers in the AB255 study","volume":"6","author":"P\u00e9rez-Grijalba","year":"2019","journal-title":"J. Prev Alzheimers Dis."},{"issue":"3","key":"10.1016\/j.cca.2025.120397_b0445","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1007\/s43440-020-00107-0","article-title":"Clinical significance of fluid biomarkers in Alzheimer's Disease","volume":"72","author":"Lewczuk","year":"2020","journal-title":"Pharmacol. Rep."},{"issue":"1","key":"10.1016\/j.cca.2025.120397_b0450","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s12035-019-01698-3","article-title":"Neurofilament light chain as a biomarker, and correlation with magnetic resonance imaging in diagnosis of CNS-related disorders","volume":"57","author":"Alirezaei","year":"2020","journal-title":"Mol. Neurobiol."},{"issue":"10","key":"10.1016\/j.cca.2025.120397_b0455","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1002\/alz.12324","article-title":"Elevated plasma neurofilament light predicts a faster rate of cognitive decline over 5 years in participants with objectively-defined subtle cognitive decline and MCI","volume":"17","author":"Bangen","year":"2021","journal-title":"Alzheimers Dement."},{"issue":"1","key":"10.1016\/j.cca.2025.120397_b0460","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/s12883-024-03728-7","article-title":"Elevated plasma neurofilament light was associated with multi-modal neuroimaging features in Alzheimer's disease signature regions and predicted future tau deposition","volume":"24","author":"Hu","year":"2024","journal-title":"BMC Neurol."},{"issue":"3","key":"10.1016\/j.cca.2025.120397_b0465","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000209537","article-title":"Blood astrocyte biomarkers in Alzheimer Disease: a systematic review and meta-analysis","volume":"103","author":"Holper","year":"2024","journal-title":"Neurology"},{"issue":"13","key":"10.1016\/j.cca.2025.120397_b0470","doi-asserted-by":"crossref","first-page":"4567","DOI":"10.1007\/s00259-022-05897-4","article-title":"Reactive astrogliosis is associated with higher cerebral glucose consumption in the early Alzheimer\u2019s continuum","volume":"49","author":"Salvad\u00f3","year":"2022","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"11","key":"10.1016\/j.cca.2025.120397_b0475","doi-asserted-by":"crossref","first-page":"4062","DOI":"10.1007\/s00586-024-08481-6","article-title":"Identification of extracellular matrix proteins in plasma as a potential biomarker for intervertebral disc degeneration","volume":"33","author":"Nayagam","year":"2024","journal-title":"Eur. Spine J."},{"key":"10.1016\/j.cca.2025.120397_b0480","article-title":"Serum proteomics reveals APOE dependent and independent protein signatures in Alzheimer's disease","author":"Gudmundsdottir","year":"2024","journal-title":"Res Sq"},{"issue":"22","key":"10.1016\/j.cca.2025.120397_b0485","doi-asserted-by":"crossref","first-page":"5108","DOI":"10.1093\/cercor\/bhac001","article-title":"Co-expression network analysis of frontal cortex during the progression of Alzheimer's disease","volume":"32","author":"Beck","year":"2022","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.cca.2025.120397_b0490","article-title":"Comprehensive proteomic analysis of the differential expression of 83 proteins following intracortical microelectrode implantation","author":"Song","year":"2024","journal-title":"Res Sq"},{"issue":"8","key":"10.1016\/j.cca.2025.120397_b0495","doi-asserted-by":"crossref","DOI":"10.3390\/cells11081367","article-title":"Blood-based biomarkers for Alzheimer's disease diagnosis and progression: an overview","volume":"11","author":"Varesi","year":"2022","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.cca.2025.120397_b0500","doi-asserted-by":"crossref","DOI":"10.1002\/alz.14442","article-title":"Plasma A\u03b2(42)\/A\u03b2(40) is sensitive to early cerebral amyloid accumulation and predicts risk of cognitive decline across the Alzheimer's disease spectrum","volume":"21","author":"Trelle","year":"2025","journal-title":"Alzheimers Dement."},{"issue":"1","key":"10.1016\/j.cca.2025.120397_b0505","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s13195-022-01117-1","article-title":"The performance of plasma amyloid beta measurements in identifying amyloid plaques in Alzheimer's disease: a literature review","volume":"14","author":"Brand","year":"2022","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.cca.2025.120397_b0510","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1120178","article-title":"Endometrial cancer diagnostic and prognostic algorithms based on proteomics, metabolomics, and clinical data: a systematic review","volume":"13","author":"Romano","year":"2023","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.cca.2025.120397_b0515","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.exger.2009.10.010","article-title":"Total and phosphorylated tau protein as biological markers of Alzheimer's disease","volume":"45","author":"Hampel","year":"2010","journal-title":"Exp. Gerontol."},{"issue":"21","key":"10.1016\/j.cca.2025.120397_b0520","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232112841","article-title":"Phosphorylated Tau in Alzheimer's disease and other tauopathies","volume":"23","author":"Rawat","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.cca.2025.120397_b0525","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s00401-021-02275-6","article-title":"Plasma p-tau231: a new biomarker for incipient Alzheimer's disease pathology","volume":"141","author":"Ashton","year":"2021","journal-title":"Acta Neuropathol."},{"issue":"4","key":"10.1016\/j.cca.2025.120397_b0530","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12040786","article-title":"Evaluating p-tau217 and p-tau231 as biomarkers for early diagnosis and differentiation of Alzheimer's disease: A narrative review","volume":"12","author":"Jarek","year":"2024","journal-title":"Biomedicines"},{"issue":"9","key":"10.1016\/j.cca.2025.120397_b0535","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.7150\/ijbs.57078","article-title":"Interaction between A\u03b2 and Tau in the pathogenesis of Alzheimer's Disease","volume":"17","author":"Zhang","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.cca.2025.120397_b0540","doi-asserted-by":"crossref","unstructured":"Thebault, S., R.A. Booth, and M.S. Freedman, Blood neurofilament light chain: the neurologist's troponin? Biomedicines, 2020. 8(11).","DOI":"10.3390\/biomedicines8110523"},{"key":"10.1016\/j.cca.2025.120397_b0545","article-title":"Elevated plasma neurofilament light was associated with multi-modal neuroimaging features in Alzheimer's Disease signature regions and predicted future tau deposition","author":"Hu","year":"2024","journal-title":"Res Sq"},{"key":"10.1016\/j.cca.2025.120397_b0550","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000001642","article-title":"Neurofilament light chain: A prognostic biomarker in amyotrophic lateral sclerosis","volume":"84","author":"Lu","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.cca.2025.120397_b0555","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.102870","article-title":"A candidate biomarker of glial fibrillary acidic protein in CSF and blood in differentiating multiple sclerosis and its subtypes: A systematic review and meta-analysis","volume":"51","author":"Sun","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.cca.2025.120397_b0560","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1375302","article-title":"Plasma GFAP, NfL and pTau 181 detect preclinical stages of dementia","volume":"15","author":"Ingannato","year":"2024","journal-title":"Front Endocrinol (lausanne)"},{"issue":"1","key":"10.1016\/j.cca.2025.120397_b0565","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13024-017-0226-4","article-title":"YKL-40 in the brain and cerebrospinal fluid of neurodegenerative dementias","volume":"12","author":"Llorens","year":"2017","journal-title":"Mol. Neurodegener."},{"issue":"9","key":"10.1016\/j.cca.2025.120397_b0570","doi-asserted-by":"crossref","DOI":"10.3390\/s23094184","article-title":"Revolutionizing the early detection of Alzheimer's disease through non-invasive biomarkers: the role of artificial intelligence and deep learning","volume":"23","author":"Vrahatis","year":"2023","journal-title":"Sensors (basel)"},{"issue":"4","key":"10.1016\/j.cca.2025.120397_b0575","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/alz.12724","article-title":"Plasma A\u03b242\/40 ratio, p-tau181, GFAP, and NfL across the Alzheimer's disease continuum: A cross-sectional and longitudinal study in the AIBL cohort","volume":"19","author":"Chatterjee","year":"2023","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.cca.2025.120397_b0580","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2147\/IJNRD.S461028","article-title":"Comparative analysis of logistic regression, gradient boosted trees, SVM, and random forest algorithms for prediction of acute kidney injury requiring dialysis after cardiac surgery","volume":"17","author":"Omar","year":"2024","journal-title":"Int J Nephrol Renovasc Dis"},{"issue":"9","key":"10.1016\/j.cca.2025.120397_b0585","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1001\/jamaneurol.2024.2619","article-title":"Plasma phosphorylated Tau 217 and A\u03b242\/40 to predict early brain a\u03b2 accumulation in people without cognitive impairment","volume":"81","author":"Janelidze","year":"2024","journal-title":"JAMA Neurol."},{"issue":"3","key":"10.1016\/j.cca.2025.120397_b0590","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.0006-341X.2002.00657.x","article-title":"Combining several screening tests: optimality of the risk score","volume":"58","author":"McIntosh","year":"2002","journal-title":"Biometrics"},{"issue":"Pt 2","key":"10.1016\/j.cca.2025.120397_b0595","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.semcancer.2017.12.008","article-title":"Understanding preanalytical variables and their effects on clinical biomarkers of oncology and immunotherapy","volume":"52","author":"Agrawal","year":"2018","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.cca.2025.120397_b0600","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.cca.2021.02.022","article-title":"Circulating calprotectin as biomarker in neutrophil-related inflammation: Pre-analytical recommendations and reference values according to sample type","volume":"517","author":"Mylemans","year":"2021","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2025.120397_b0605","doi-asserted-by":"crossref","DOI":"10.1016\/j.geoderma.2023.116724","article-title":"An interlaboratory comparison of mid-infrared spectra acquisition: Instruments and procedures matter","volume":"440","author":"Safanelli","year":"2023","journal-title":"Geoderma"},{"issue":"12","key":"10.1016\/j.cca.2025.120397_b0610","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1182\/blood.2019004399","article-title":"Rapid single-molecule digital detection of protein biomarkers for continuous monitoring of systemic immune disorders","volume":"137","author":"Song","year":"2021","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.cca.2025.120397_b0615","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.3233\/JAD-215093","article-title":"Novel ultrasensitive detection technologies for the identification of early and minimally invasive Alzheimer's disease blood biomarkers","volume":"86","author":"\u00c1lvarez-S\u00e1nchez","year":"2022","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.cca.2025.120397_b0620","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanhl.2025.100715","article-title":"Blood biomarkers of Alzheimer's disease and 12-year muscle strength trajectories in community-dwelling older adults: a cohort study","author":"Ornago","year":"2025","journal-title":"Lancet Healthy Longev"},{"key":"10.1016\/j.cca.2025.120397_b0625","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1590909","article-title":"The role of monocytes and macrophages in the progression of Alzheimer's disease","volume":"16","author":"Nie","year":"2025","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.cca.2025.120397_b0630","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s00401-021-02275-6","article-title":"Plasma p-tau231: a new biomarker for incipient Alzheimer\u2019s disease pathology","volume":"141","author":"Ashton","year":"2021","journal-title":"Acta Neuropathol."},{"issue":"5","key":"10.1016\/j.cca.2025.120397_b0635","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/s43587-023-00403-3","article-title":"Blood biomarkers for Alzheimer's disease in clinical practice and trials","volume":"3","author":"Hansson","year":"2023","journal-title":"Nat. Aging"},{"issue":"3","key":"10.1016\/j.cca.2025.120397_b0640","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70066","article-title":"Plasma protein risk scores for mild cognitive impairment and Alzheimer's disease in the Framingham heart study","volume":"21","author":"Rehman","year":"2025","journal-title":"Alzheimers Dement."},{"issue":"3","key":"10.1016\/j.cca.2025.120397_b0645","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.115382","article-title":"Secreted neurofilament light chain after neuronal damage induces myeloid cell activation and neuroinflammation","volume":"44","author":"Kahn","year":"2025","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.cca.2025.120397_b0650","doi-asserted-by":"crossref","DOI":"10.1111\/ene.16089","article-title":"Plasma neurofilament light chain predicts Alzheimer's disease in patients with subjective cognitive decline and mild cognitive impairment: A cross-sectional and longitudinal study","volume":"31","author":"Mazzeo","year":"2024","journal-title":"Eur. J. Neurol."},{"issue":"4","key":"10.1016\/j.cca.2025.120397_b0655","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1212\/WNL.0000000000000055","article-title":"Higher risk of progression to dementia in mild cognitive impairment cases who revert to normal","volume":"82","author":"Roberts","year":"2014","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.cca.2025.120397_b0660","doi-asserted-by":"crossref","DOI":"10.1002\/alz.14458","article-title":"Diagnostic accuracy of phosphorylated tau217 in detecting Alzheimer's disease pathology among cognitively impaired and unimpaired: A systematic review and meta-analysis","volume":"21","author":"Khalafi","year":"2025","journal-title":"Alzheimers Dement."},{"issue":"6","key":"10.1016\/j.cca.2025.120397_b0665","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1002\/alz.12906","article-title":"Plasma p-tau217 predicts in vivo brain pathology and cognition in autosomal dominant Alzheimer's disease","volume":"19","author":"Aguillon","year":"2023","journal-title":"Alzheimers Dement."},{"issue":"1","key":"10.1016\/j.cca.2025.120397_b0670","doi-asserted-by":"crossref","first-page":"15","DOI":"10.14283\/jpad.2018.2","article-title":"Detecting treatment group differences in alzheimer's disease clinical trials: a comparison of Alzheimer's disease assessment scale - cognitive subscale (ADAS-Cog) and the clinical dementia rating - sum of boxes (CDR-SB)","volume":"5","author":"Wessels","year":"2018","journal-title":"J. Prev Alzheimers Dis."},{"issue":"1","key":"10.1016\/j.cca.2025.120397_b0675","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1186\/s13195-024-01642-1","article-title":"Longitudinal trajectory of plasma p-tau217 in cognitively unimpaired subjects","volume":"16","author":"Mart\u00ednez-Dubarbie","year":"2024","journal-title":"Alzheimers Res. Ther."},{"issue":"1","key":"10.1016\/j.cca.2025.120397_b0680","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s13195-020-00657-8","article-title":"Association of glial and neuronal degeneration markers with Alzheimer's disease cerebrospinal fluid profile and cognitive functions","volume":"12","author":"Teitsdottir","year":"2020","journal-title":"Alzheimers Res. Ther."},{"issue":"1","key":"10.1016\/j.cca.2025.120397_b0685","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13195-021-00804-9","article-title":"Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment","volume":"13","author":"Cicognola","year":"2021","journal-title":"Alzheimers Res. Ther."},{"issue":"10","key":"10.1016\/j.cca.2025.120397_b0690","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.biopsych.2010.08.025","article-title":"YKL-40: a novel prognostic fluid biomarker for preclinical Alzheimer's disease","volume":"68","author":"Craig-Schapiro","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.cca.2025.120397_b0695","doi-asserted-by":"crossref","unstructured":"Diagnostic Performance of Plasma P\u2010tau217, NfL, and GFAP for Predicting Alzheimer\u2019s Disease Neuropathology Across Diverse Neurodegenerative Syndromes. Alzheimers Dement., 2024. 20(Suppl 2): p. e090596. doi: 10.1002\/alz.090596. eCollection 2024 Dec.","DOI":"10.1002\/alz.090596"},{"issue":"1","key":"10.1016\/j.cca.2025.120397_b0700","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s12974-024-03163-y","article-title":"Tracking neuroinflammatory biomarkers in Alzheimer's disease: a strategy for individualized therapeutic approaches?","volume":"21","author":"Lista","year":"2024","journal-title":"J. Neuroinflammation"},{"issue":"8","key":"10.1016\/j.cca.2025.120397_b0705","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27082411","article-title":"Applications of tandem mass spectrometry (MS\/MS) in protein analysis for biomedical research","volume":"27","author":"Neagu","year":"2022","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.cca.2025.120397_b0710","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1214\/10-AOAS341","article-title":"Liquid chromatography mass spectrometry-based proteomics: biological and technological aspects","volume":"4","author":"Karpievitch","year":"2010","journal-title":"Ann. Appl. Stat."},{"issue":"3","key":"10.1016\/j.cca.2025.120397_b0715","article-title":"Significance of blood and cerebrospinal fluid biomarkers for Alzheimer's disease: sensitivity, specificity and potential for clinical use","volume":"10","author":"d'Abramo","year":"2020","journal-title":"J Pers Med"},{"issue":"10","key":"10.1016\/j.cca.2025.120397_b0720","doi-asserted-by":"crossref","first-page":"7162","DOI":"10.1021\/acs.analchem.0c00655","article-title":"27-Plex tandem mass tag mass spectrometry for profiling brain proteome in Alzheimer's disease","volume":"92","author":"Wang","year":"2020","journal-title":"Anal. Chem."},{"issue":"7","key":"10.1016\/j.cca.2025.120397_b0725","doi-asserted-by":"crossref","DOI":"10.3390\/cells10071588","article-title":"Age-dependent hippocampal proteomics in the APP\/PS1 alzheimer mouse model: a comparative analysis with classical SWATH\/DIA and directDIA approaches","volume":"10","author":"van der Spek","year":"2021","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.cca.2025.120397_b0730","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s12987-024-00581-1","article-title":"Data-independent acquisition proteomic analysis of the brain microvasculature in Alzheimer's disease identifies major pathways of dysfunction and upregulation of cytoprotective responses","volume":"21","author":"Erickson","year":"2024","journal-title":"Fluids Barriers CNS"},{"issue":"1","key":"10.1016\/j.cca.2025.120397_b0735","doi-asserted-by":"crossref","first-page":"5348","DOI":"10.1038\/s41467-021-25566-8","article-title":"Digital immunoassay for biomarker concentration quantification using solid-state nanopores","volume":"12","author":"He","year":"2021","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.cca.2025.120397_b0740","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1001\/archneurol.2008.565","article-title":"A specific enzyme-linked immunosorbent assay for measuring beta-amyloid protein oligomers in human plasma and brain tissue of patients with Alzheimer disease","volume":"66","author":"Xia","year":"2009","journal-title":"Arch. Neurol."},{"issue":"5","key":"10.1016\/j.cca.2025.120397_b0745","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.8903","article-title":"APOE4, blood neurodegenerative biomarkers, and cognitive decline in community-dwelling older adults","volume":"8","author":"Ng","year":"2025","journal-title":"JAMA Netw. Open"},{"issue":"6","key":"10.1016\/j.cca.2025.120397_b0750","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00415-025-13145-6","article-title":"Associations between A\u03b240, A\u03b242, and tau and postoperative delirium in older adults undergoing cardiac surgery","volume":"272","author":"McKay","year":"2025","journal-title":"J. Neurol."},{"issue":"6","key":"10.1016\/j.cca.2025.120397_b0755","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/S1474-4422(25)00154-1","article-title":"A new characterisation of acute traumatic brain injury: the NIH-NINDS TBI Classification and Nomenclature Initiative","volume":"24","author":"Manley","year":"2025","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.cca.2025.120397_b0760","doi-asserted-by":"crossref","unstructured":"Ma, T., et al., Differential DNA methylation in blood as potential mediator of the association between ambient PM (2.5) and cerebrospinal fluid biomarkers of Alzheimer's disease among a cognitively normal population-based cohort. medRxiv, 2025.","DOI":"10.1101\/2025.04.15.25325910"},{"key":"10.1016\/j.cca.2025.120397_b0765","doi-asserted-by":"crossref","DOI":"10.1177\/13872877251344881","article-title":"Double product is longitudinally associated with reduced cognitive function in type 2 diabetes with insights from cross-lagged panel analysis and mediation by leucine-rich \u03b1-2-glycoprotein 1","author":"Low","year":"2025","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.cca.2025.120397_b0770","article-title":"Neuron-derived extracellular vesicles: emerging regulators in central nervous system disease progression","author":"Liu","year":"2025","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.cca.2025.120397_b0775","doi-asserted-by":"crossref","DOI":"10.1177\/13872877251338063","article-title":"How much can biomarkers explain sociodemographic inequalities in cognitive dysfunction and cognitive impairment? Results from a machine learning model in the Health and Retirement Study","author":"Klopack","year":"2025","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.cca.2025.120397_b0780","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/bs.mie.2025.01.048","article-title":"Measurements of acrolein adducts resulting from polyamine catabolism","volume":"715","author":"Kashiwagi","year":"2025","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.cca.2025.120397_b0785","doi-asserted-by":"crossref","DOI":"10.2174\/0115672050388220250511174043","article-title":"Predictive value of complete blood count parameters for alzheimer's disease in relation to periodontal status","author":"Karaduran","year":"2025","journal-title":"Curr. Alzheimer Res."},{"issue":"5","key":"10.1016\/j.cca.2025.120397_b0790","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.8842","article-title":"Cerebral amyloid angiopathy and downstream alzheimer disease plasma biomarkers","volume":"8","author":"Kang","year":"2025","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.cca.2025.120397_b0795","doi-asserted-by":"crossref","DOI":"10.1038\/s43587-025-00872-8","article-title":"Large-scale plasma proteomic profiling unveils diagnostic biomarkers and pathways for Alzheimer's disease","author":"Heo","year":"2025","journal-title":"Nat. Aging"},{"issue":"5","key":"10.1016\/j.cca.2025.120397_b0800","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70274","article-title":"Neuroimaging and plasma biomarker differences and commonalities in Lewy body dementia subtypes","volume":"21","author":"Hannaway","year":"2025","journal-title":"Alzheimers Dement."},{"issue":"5","key":"10.1016\/j.cca.2025.120397_b0805","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70294","article-title":"The Alzheimer's biomarker consortium-down syndrome (ABC-DS): A 10-year report","volume":"21","author":"Handen","year":"2025","journal-title":"Alzheimers Dement."},{"issue":"5","key":"10.1016\/j.cca.2025.120397_b0810","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.70436","article-title":"The soluble platelet-derived growth factor \u03b2 receptor induces postoperative delirium by downregulating the clearance of \u03b2-amyloid in the brain","volume":"15","author":"Guo","year":"2025","journal-title":"Brain Behav."},{"key":"10.1016\/j.cca.2025.120397_b0815","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3389\/fneur.2015.00236","article-title":"Blood-based proteomic biomarkers of alzheimer's disease pathology","volume":"6","author":"Baird","year":"2015","journal-title":"Front. Neurol."},{"key":"10.1016\/j.cca.2025.120397_b0820","doi-asserted-by":"crossref","DOI":"10.1373\/clinchem.2014.228783","article-title":"Preanalytical variables affecting the integrity of human biospecimens in biobanking","volume":"61","author":"Ellervik","year":"2015","journal-title":"Clin. Chem."},{"issue":"5","key":"10.1016\/j.cca.2025.120397_b0825","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/s41591-019-0415-5","article-title":"A signature of circulating inflammatory proteins and development of end-stage renal disease in diabetes","volume":"25","author":"Niewczas","year":"2019","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.cca.2025.120397_b0830","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1007\/s40120-024-00658-x","article-title":"Navigating the landscape of plasma biomarkers in Alzheimer's disease: focus on past, present, and future clinical applications","volume":"13","author":"Ankeny","year":"2024","journal-title":"Neurol. Ther."},{"issue":"25","key":"10.1016\/j.cca.2025.120397_b0835","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1016\/j.vaccine.2022.04.030","article-title":"Overcoming COVID-19 vaccine hesitancy among ethnic minorities: A systematic review of UK studies","volume":"40","author":"Hussain","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.cca.2025.120397_b0840","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.nbd.2016.07.007","article-title":"The blood-brain barrier in Alzheimer's disease","volume":"107","author":"Zenaro","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.cca.2025.120397_b0845","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2025.120289","article-title":"Immuno-PCR: A high-sensitivity approach for biomarker analysis","volume":"573","author":"Shi","year":"2025","journal-title":"Clin. Chim. Acta"},{"issue":"5","key":"10.1016\/j.cca.2025.120397_b0850","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2025.104360","article-title":"Artificial intelligence in preclinical research: enhancing digital twins and organ-on-chip to reduce animal testing","volume":"30","author":"Gangwal","year":"2025","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.cca.2025.120397_b0855","doi-asserted-by":"crossref","DOI":"10.1016\/j.cct.2021.106486","article-title":"Design and methods of a randomized trial testing the novel Wellness Intervention for Smokers Living with HIV (WISH)","volume":"110","author":"McClure","year":"2021","journal-title":"Contemp. Clin. Trials"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898125002761?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898125002761?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T11:53:04Z","timestamp":1756036384000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898125002761"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":171,"alternative-id":["S0009898125002761"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2025.120397","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emerging blood biomarkers in Alzheimer\u2019s disease: a proteomic perspective","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2025.120397","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"120397"}}